BSE filing, NSE: PRECISIO. Summary written from the filing by ALFA Finder's alert engine.
Precision Electronics Ltd: key numbers
- Share price
- ₹171.45
- Market cap
- ₹237.4 Cr
- Revenue (annual)
- ₹79.02 Cr
- Net profit (annual)
- ₹0.61 Cr
- P/E (TTM)
- -161.9×Sector 43.1×
- Promoter holding
- 50.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Precision Electronics Ltd
All →Precision Electronics Other Announcement
Precision Electronics Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) of SEBI LODR Regulations for the quarter ended September 30, 2026.
Precision Electronics Other Announcement
Precision Electronics Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, received from its Registrar, Skyline Financial Services.
Precision Electronics Annual General Meeting
Precision Electronics Limited held its 47th AGM on September 16, 2026. Resolutions included director re-appointment, related party transactions, and land disposal.
Precision Electronics Other Announcement
Precision Electronics received 'Consent to Operate' (CTO) for its Ballabhgarh manufacturing facility from the Haryana State Pollution Control Board, valid until December 2030.
Precision Electronics Other Announcement
Precision Electronics Limited has intimated the book closure dates from September 10, 2026, to September 16, 2026, for its 47th Annual General Meeting.
Precision Electronics Annual General Meeting
Precision Electronics Limited scheduled its 47th Annual General Meeting for September 16, 2026. The agenda includes related party transaction approvals and the sale of company land.
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.